• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Prime Medicine Inc (NQ: PRME )

    4.420 +0.280 (+6.76%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 461,900
    Open 4.190
    Bid (Size) 4.420 (23)
    Ask (Size) 4.430 (71)
    Prev. Close 4.140
    Today's Range 4.180 - 4.430
    52wk Range 3.990 - 13.60
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024
    PRME stock results show that Prime Medicine missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates
    From Prime Medicine, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -49.54%
    -49.54%
    1 Month
    -19.49%
    -19.49%
    3 Month
    -36.17%
    -36.17%
    6 Month
    -46.88%
    -46.88%
    1 Year
    -65.25%
    -65.25%

    More News

    Read More
    Prime Medicine to Present at Upcoming Investor Conferences
    From Prime Medicine, Inc.
    Via GlobeNewswire
    If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
    Via InvestorPlace
    Exposures Product Safety
    Recap: Prime Medicine Q4 Earnings
    Via Benzinga
    Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio
    Via The Motley Fool
    Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
    Via InvestorPlace
    Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
    Via InvestorPlace
    Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
    From Prime Medicine, Inc.
    Via GlobeNewswire
    PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024
    Via InvestorPlace
    Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
    From Prime Medicine, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
    From Prime Medicine, Inc.
    Via GlobeNewswire
    2 Magnificent Growth Stocks With Room to Run
    Via The Motley Fool
    Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
    Via InvestorPlace
    Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
    Via InvestorPlace
    Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine to Participate in Upcoming Investor Conferences
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.